Paper39938579
Atrial fibrillation burden and management in cardiomyopathies: Current evidence and unmet needs.
Antonopoulos AS and 11 others. Trends Cardiovasc Med, 2025. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Atrial fibrillation burden and management in cardiomyopathies: Current evidence and unmet needs. Papers, record 39938579. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39938579
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Atrial fibrillation burden and management in cardiomyopathies: Current evidence and unmet needs.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Atrial Fibrillation | Major topic |
| Anti-Arrhythmia Agents | Major topic |
| Cardiomyopathies | Major topic |
| Catheter Ablation | Major topic |
| Heart Rate | Major topic |
| Humans | |
| Risk Assessment | |
| Risk Factors | |
| Treatment Outcome | |
| Prevalence | |
| Cost of Illness |
Source PubMed
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42935515 | Effects of RhBNP combined with immune modulation on immune function and short-term clinical outcomes in patients with atrial fibrillation and heart failure. | Am Heart J Plus | 2026 | https://conductscience.org/library/papers/42935515 | PubMed |
| 42703458 | Freely available genomic datasets for atrial fibrillation research: current resources and analytical pipeline. | Front Genet | 2026 | https://conductscience.org/library/papers/42703458 | PubMed |
| 42355780 | Atrial Fibrillation Risk Management and Emerging Therapies. | J Clin Med | 2026 | https://conductscience.org/library/papers/42355780 | PubMed |
| 42077455 | Thyroid dysfunction and risk of atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy: a multicenter cohort study. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42077455 | PubMed |
| 41417169 | Atrial fibrillation: from pathogenesis to novel treatment options. | Mol Biomed | 2025 | https://conductscience.org/library/papers/41417169 | PubMed |
| 41010036 | Genotype-Phenotype Relationship in Hypertrophic Cardiomyopathy. | Genes (Basel) | 2025 | https://conductscience.org/library/papers/41010036 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39938579
GET https://conductscience.org/api/papers/v1/39938579/authors